newsfilter
← Latest News
GlobeNewswire·

Inozyme Pharma to Host Virtual Investor and Analyst Event on Sep. 26, 2023

BOSTON, Sept. 20, 2023 (GLOBE NEWSWIRE) -- Inozyme Pharma, Inc. (NASDAQ:INZY)("Inozyme" or the "Company"), a clinical-stage rare disease biopharmaceutical company developing novel therapeutics for the treatment of